Matthew Autterson is a popular name in investment banking circles. He is a reputable investor who has been at the helm of some of the biggest companies in the financial industry. He is also a generous philanthropist. Here is an overview of his rise to success.
Matthew Autterson studied Accounting and Finance at Buena Vista University. He graduated from the university with a degree in accounting and a minor in finance. He also undertook the University of Denver Graduate Tax Program.
Autterson worked briefly as a lecturer of finance at North Iowa Community College. He also practiced as a CPA specialist briefly before venturing into the financial and investment industries.
Matthew Autterson’s first occupation in the financial industry was at First Trust Corporation, a subsidiary of Fiserv. He ventured out on his own soon after 1982 when he joined a team which formed a new Colorado state chartered trust company. The team formed the company as a subsidiary of New York based Integrated Resources, Inc., a respectable financial services company. They named the company Resources Trust Company, and Autterson became its President in 1986.
Today, Matthew Autterson is a member of the Board of Directors at Falci Adaptive Biosystems (FAB). He has also held many other senior positions in the past, some of which he holds to date. Some of these positions include a member of Board of the Denver Zoo, member of Board of the Denver Zoological Foundation as well as the Webb-Waring Foundation. He is also a former member of the Young Presidents Organization as well as the World Presidents Organization. He is also the Chairman of the Board of Directors of Denver Hospice.
Besides being a member of the Board of Directors at FAB, Matthew Autterson is also the President and CEO of CNS Bioscience, Inc. It is a clinical-state drug development company that was founded by Scott Falci, M.D. in 2013 – Autterson has always been interested in neuropathic conditions.
Matthew Autterson, the Philanthropist
Matthew Autterson shows great interest in medical welfare and wildlife. To this end, he regularly donates to organizations that endeavor to find cures to a wide range of neuropathic conditions – he is even at the forefront of one of these companies: CNS Bioscience, Inc. Autterson is also engaged in many environmental and wildlife conservation organizations. He donates to wildlife charities and serves as a member of the board of directors of several wildlife protection associations.